Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cadonilimab”

142 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 142 results

Testing effectiveness (Phase 2)Looking for participantsNCT05926700
What this trial is testing

Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment

Who this might be right for
Soft Tissue Sarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 27
Testing effectiveness (Phase 2)UnknownNCT05821361
What this trial is testing

HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Unrescetable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT06178601
What this trial is testing

RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Shanxi Province Cancer Hospital 36
Large-scale testing (Phase 3)Active Not RecruitingNCT05587374
What this trial is testing

Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 490
Testing effectiveness (Phase 2)Looking for participantsNCT06035224
What this trial is testing

Cadonilimab（AK104） Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
RenJi Hospital 28
Large-scale testing (Phase 3)Looking for participantsNCT06221748
What this trial is testing

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
RemeGen Co., Ltd. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06202313
What this trial is testing

Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Shengjing Hospital 128
Testing effectiveness (Phase 2)UnknownNCT06153368
What this trial is testing

Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06789848
What this trial is testing

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Who this might be right for
Advanced Hepatocellular CarcinomaRefractory Hepatocellular CarcinomaBiliary Tract Cancer
University of Texas Southwestern Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT05792735
What this trial is testing

Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Carcinoma
Shenzhen People's Hospital 27
Testing effectiveness (Phase 2)Looking for participantsNCT06438822
What this trial is testing

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
West China Hospital 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07450963
What this trial is testing

Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT

Who this might be right for
Locally Advanced Cervical Cancer
Ruijin Hospital 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT07400536
What this trial is testing

A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT

Who this might be right for
Locally Advanced Cervical Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 378
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06196775
What this trial is testing

Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Harbin Medical University 36
Testing effectiveness (Phase 2)Looking for participantsNCT06406634
What this trial is testing

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06793813
What this trial is testing

Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage IVB Lung CancerNon-Squamous
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 44
Large-scale testing (Phase 3)Looking for participantsNCT05941741
What this trial is testing

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Who this might be right for
Nasopharyngeal CarcinomaImmune Checkpoint InhibitorRadiotherapy+1 more
Sun Yat-sen University 380
Testing effectiveness (Phase 2)Looking for participantsNCT06406426
What this trial is testing

Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albumin

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Fudan University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07263919
What this trial is testing

Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Akeso 90
Load More Results